Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.42 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.39 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.39 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.38 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.38 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.38 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | RARA | P10276 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2196174 | 0.86 | CYP2C19 (0.34) | GABBR2GABRB1GABRB2GABBR1RARA | |
| SCHEMBL1397176 | 0.80 | CYP19A1 (0.45) | GABBR2GABRB1GABRB2GABBR1CYP19A1 | |
| SCHEMBL1397068 | 0.79 | KMT2A (0.48) | GABBR2GABRB1GABRB2GABBR1CYP19A1 | |
| SCHEMBL6066461 | 0.79 | KMT2A (0.48) | GABBR2GABRB1GABRB2GABBR1CYP19A1 | |
| SCHEMBL1397163 | 0.78 | CHRNA7 (0.42) | GABBR2GABRB1GABRB2GABBR1GRIN2D | |
| SCHEMBL7705806 | 0.76 | PAM (0.49) | GABBR2GABRB1GABRB2GABBR1CYP19A1 | |
| SCHEMBL377478 | 0.76 | HDAC1 (0.52) | HDAC3TNKSHDAC4HDAC1HCAR2 | |
| SCHEMBL6305516 | 0.75 | GABBR2 (0.41) | GABBR2GABRB1GABRB2GABBR1CYP19A1 | |
| SCHEMBL7247469 | 0.72 | GABBR2 (0.39) | GABBR2GABRB1GABRB2GABBR1CYP19A1 | |
| SCHEMBL6252722 | 0.72 | KMT2A (0.47) | HDAC3TNKSHDAC4HDAC1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107207456-B | Latent acids and their use | 巴斯夫欧洲公司 | 2021-05-04 | — | — | CN | disclosed |
| EP-3253735-B1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2021-03-31 | — | — | EP | disclosed |
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2018-01-11 | — | — | US | disclosed |
| WO-2016124493-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2016-08-11 | — | — | WO | disclosed |
| EP-2197840-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2013-11-06 | — | — | EP | disclosed |
| EP-1472576-B1 | SULFONATE DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-2197869-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2013-04-24 | — | — | EP | disclosed |
| EP-2197839-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2013-01-02 | — | — | EP | disclosed |
| EP-2349993-B1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-20110171569-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | BASF SE (DE) | 2011-07-14 | — | — | US | disclosed |
| EP-1320785-B1 | OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | BASF SE (DE) | 2010-02-17 | — | — | EP | disclosed |
| EP-1344109-B1 | ONIUM SALTS AND THE USE THEROF AS LATENT ACIDS | CIBA HOLDING INC (CH) | 2008-05-07 | — | — | EP | disclosed |
| US-20060068325-A1 | Oxime derivatives and the use thereof as latent acids | YAMATO HITOSHI | 2006-03-30 | — | — | US | disclosed |
| EP-1392675-B1 | SUBSTITUTED OXIME DERIVATIVES AND THE USE THEREOF AS LATENT ACIDS | CIBA SC HOLDING AG (CH) | 2005-02-09 | — | — | EP | disclosed |
| US-6261738-B1 | LATENT CURING CATALYSTS FOR PHOTORESISTS SUCH AS 2,2,2-TRIFLUORO-1-PHENYL-ETHANONE OXIME-O-METHYL SULFONATE | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | LTA, C1S, C9 | GABBR2 985/4885GABRB1 1542/4885GABRB2 1534/4885 |
| US-20110171569-A1 | SULFONIUM DERIVATIVES AND THE USE THEROF AS LATENT ACIDS | NR2E3, HCAR3, HRH4 | GABBR2 673/4885GABRB1 755/4885GABRB2 774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.